Success after solid organ transplantation is dependent on the proper balance of immunosuppression to prevent rejection of the allograft while limiting the risk of developing infections and malignancy. We present a 9-year-old girl, remote from transplant, who presented with airway plaque after a change in immunosuppression to include the mTOR inhibitor sirolimus. Differential diagnosis included direct medication side effect, infection, and neoplasia.
Keywords: EBV; airway; heart transplant; immunosuppression; mTOR inhibitor; post-transplant lymphoproliferative disorder.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.